|
Volumn 3, Issue 4, 1983, Pages 383-434
|
Phenytoin: Basic and clinical pharmacology
a,b a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM;
ETHOSUXIMIDE;
ETHOTOIN;
NEUROTRANSMITTER;
PHENACEMIDE;
PHENOBARBITAL;
PHENYTOIN;
SODIUM;
TRIMETHADIONE;
ADVERSE DRUG REACTION;
BIOAVAILABILITY;
BLOOD AND HEMOPOIETIC SYSTEM;
BONE;
BONE MARROW APLASIA;
CENTRAL NERVOUS SYSTEM;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HYPERSENSITIVITY;
DRUG INTERACTION;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG TOXICITY;
ENDOCRINE SYSTEM;
EPILEPSY;
FETAL HYDANTOIN SYNDROME;
FOLIC ACID DEFICIENCY;
GINGIVA HYPERPLASIA;
GLUCOSE INTOLERANCE;
HUMAN;
INTOXICATION;
MOUTH;
NERVOUS SYSTEM;
NEUROPATHY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
OSTEOMALACIA;
PHARMACOKINETICS;
PHARMACOLOGY;
REVIEW;
THERAPY;
THYROID DISEASE;
ANIMAL;
BIOLOGICAL AVAILABILITY;
BIOTRANSFORMATION;
CHEMISTRY;
CHEMISTRY, PHYSICAL;
HUMAN;
INTESTINAL ABSORPTION;
PHENYTOIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
TISSUE DISTRIBUTION;
|
EID: 0021039509
PISSN: 01986325
EISSN: 10981128
Source Type: Journal
DOI: 10.1002/med.2610030403 Document Type: Article |
Times cited : (36)
|
References (259)
|